<p>Matthew Halpert, PhD earned his doctorate in immunology after a 5-year enrollment at the University of Alabama-Birmingham graduate school, and joined Baylor College of Medicine in 2011 as an academic researcher. While in the Texas Medical Center, Dr. Halpert made numerous key discoveries regarding previously unrecognized mechanisms within our immune system, and importantly, how those mechanisms could be naturally utilized to reprogram an immune response to eliminate a target (such as cancerous cells). This science was studied in depth, worked on extensively, and progressed immensely by the efforts of Dr. Halpert, as partially evidenced by his numerous peer-reviewed publications in various top-notch science and medical journals, as well as his ownership of over a dozen patents. Within the previous decade, Dr. Halpert has successfully launched a not-for-profit charity to help support such research efforts, a “traditional” biotech venture designed to carry this science through various FDA clinical trials and towards regulatory approvals, and a Compassionate Use clinic (“Immunocine”) in Cancun, Mexico currently offering high integrity personalized immunotherapy options based on the same research and to patients which are ineligible for any of the clinical trials. Over this period of time, Dr. Halpert has been solicited to assist other biotech ventures, academic initiatives, FDA efforts, precision medicine conferences, and more as a growing Key Opinion Leader in this burgeoning space of personalized cancer care.</p>
